CRSP - Crispr Therapeutics AG - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRSP is currently covered by 21 analysts with an average price target of $75.16. This is a potential upside of $23.33 (45.01%) from yesterday's end of day stock price of $51.83.

Crispr Therapeutics AG's activity chart (see below) currently has 246 price targets and 235 ratings on display. The stock rating distribution of CRSP is 64.2% BUY, 28.4% HOLD and 7.41% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.43% with an average time for these price targets to be met of 102.59 days.

Highest price target for CRSP is $105, Lowest price target is $32, average price target is $74.74.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 07-Aug-2025. First documented stock forecast 14-Nov-2016.

Currently out of the existing stock ratings of CRSP, 52 are a BUY (64.2%), 23 are a HOLD (28.4%), 6 are a SELL (7.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$28.17 (54.35%)

$65

24 days ago
(07-Aug-2025)

4/5 (80%)

$24.04 (42.96%)

100

Hold

$56

$4.17 (8.05%)

$42

25 days ago
(06-Aug-2025)

15/18 (83.33%)

$-0.34 (-0.60%)

131

Hold

$42

$-9.83 (-18.97%)

$48

26 days ago
(05-Aug-2025)

11/13 (84.62%)

$-13.59 (-24.45%)

178

Buy

$78

$26.17 (50.49%)

$85

1 months 9 days ago
(22-Jul-2025)

2/4 (50%)

$12.07 (18.31%)

32

Buy

$81

$29.17 (56.28%)

$81

1 months 23 days ago
(08-Jul-2025)

8/23 (34.78%)

$26.18 (47.76%)

214

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?

On average it took 102.59 days on average for the stock forecasts to be realized with a an average price target met ratio 61.43

Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on CRSP

Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?

Maury Raycroft with highest potential upside - $126.61

Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?

Tyler Van Buren with lowest potential downside - -$21.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?